Carotid plaque specimens and pertinent medical histories were obtained from 76 patients undergoing CEA in the Department of Surgery at the Ochsner Clinic with no significant differences in age, sex, lipid profile, smoking, or the presence of diabetes mellitus between the groups (Table) . Similar to our previous finding, 7 there was a significant increase in miR-221/miR-222 expression in diabetic versus nondiabetic patients (P<0.01; Figure I in the online-only Data Supplement). Patients were stratified into 3 groups: without previous neurological events (asymptomatic, n=31), with a previous neurological event within 5 days of the CEA (urgent, n=25), and undergoing CEA >5 days after a neurological event (symptomatic, n=20). miRNAs and mRNAs of interest were measured in the plaque shoulder by real-time polymerase chain reaction using the primers listed in Table  I in the online-only Data Supplement. A more detailed Methods is available in the online-only Data Supplement.
C arotid plaque rupture leads to acute neurological symptoms, and, similarly, coronary plaque atheroembolization leads to acute coronary syndrome. Loss of vascular smooth muscle cells (VSMCs) in the plaque shoulder region of the fibrous cap has been implicated in plaque rupture. 1 MicroRNA-221 and microRNA-222 (miR-221/miR-222) are short noncoding RNAs that inhibit the expression of the cyclin-dependent kinase inhibitor, p27 Kip1 , promoting VSMC proliferation and intimal thickening. 2, 3 In contrast, miR-145 promotes VSMC differentiation, as well as decreased intimal thickening and atherosclerotic plaque formation in animal models. [4] [5] [6] The present study aimed to investigate the role of expression of these miRNAs in atherosclerotic plaque rupture. We measured miR-221/miR-222 and miR-145 in carotid plaque shoulder segments from patients undergoing carotid endarterectomy (CEA) and stratified the data according to the time between the CEA and the neurological event. Here, we report that miR-221/miR-222 expression is significantly decreased acutely after plaque rupture and exhibits a rapid return to prerupture levels.
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Results
The urgent group exhibited a significant decrease in miR-221/miR-222, but not in miR-145, when compared with the asymptomatic and symptomatic groups ( 8, 9 c-Kit and the signal transducer and activator of transcription 5A, remained unchanged across the groups, suggesting neovascularization is not altered by the changes in expression of miR-221/miR-222 that occur with rupture. These data suggest a role for loss of miR-221/miR-222 inhibition of p27
Kip1 in the thinning of the fibrous cap that promotes plaque instability and rupture.
Discussion
This is the first demonstration that miR-221/miR-222 expression in the plaque shoulder is decreased acutely after plaque rupture. The loss of miR-221/222 was accompanied by an increase in the mRNA encoding its target, p27 Kip1 . Loss of p27
Kip1 through increased miR-221/miR-222 expression results in increased intimal thickening in animal models of vascular injury. 3 VSMCs isolated from advanced atherosclerotic plaques exhibit lower proliferation rates. 10, 11 Similarly, VSMCs isolated from CEA specimens obtained from asymptomatic patients exhibit higher proliferative responses and lower p27
Kip1 levels than those obtained from symptomatic patients. 12 Our data support a role for miR-221/miR-222 in the intimal thickening associated with plaque development, and that loss of miR-221/222 may underlie the reduced VSMC proliferation associated with fibrous cap thinning and plaque rupture. Downregulation of miR-221/miR-222 has also been implicated in the regulation of plaque neovascularization and monocyte differentiation to macrophages. 9, 13 Although we focused our studies on the effects of loss of miR-221/miR-222 in VSMCs, additional studies examining the role of miR-221/ miR-222 in regulating plaque neovascularization and macrophage accumulation are, therefore, warranted. By focusing on carotid plaques obtained from patients undergoing urgent CEAs, we were able to identify modulations in miRNA expression that occur acutely with plaque rupture, but would not be detected in the standard symptomatic patient. Namely, that miR-221/miR-222 expression is reduced in the carotid plaque shoulder at the time of rupture and then returns to prerupture levels within 2 weeks. It is not possible, however, to determine whether the decrease in miR-221/miR-222 occurs before or as a result of plaque rupture. These data highlight the unique value of obtaining samples immediately after an acute neurological event when examining the mechanism underlying plaque rupture and suggest a link between miR-221/miR-222 and cell proliferation in this region.
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